Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 32753-32754 [2016-12149]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
accordance with law, the Receiver will
be making a final dividend payment to
proven creditors.
Based upon the foregoing, the
Receiver has determined that the
continued existence of the receivership
will serve no useful purpose.
Consequently, notice is given that the
receivership shall be terminated, to be
effective no sooner than thirty days after
the date of this Notice. If any person
wishes to comment concerning the
termination of the receivership, such
comment must be made in writing and
sent within thirty days of the date of
this Notice to: Federal Deposit
Insurance Corporation, Division of
Resolutions and Receiverships,
Attention: Receivership Oversight
Department 34.6, 1601 Bryan Street,
Dallas, TX 75201.
No comments concerning the
termination of this receivership will be
considered which are not sent within
this time frame.
Date: May 19, 2016.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
FEDERAL ELECTION COMMISSION
Sunshine Act Meetings
Federal Election Commission.
& TIME: Thursday, May 19, 2016
at 10:00 a.m.
PLACE: 999 E Street, NW., Washington,
DC (ninth floor).
STATUS: This meeting will be open to
the public.
Federal Register Notice of Previous
Announcement—81 FR 30304.
The Following Item Was Also
Discussed: REG 2014–01 Outline of
Draft NPRM Implementing Party
Segregated Accounts.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
AGENCY:
DATE
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2016–12298 Filed 5–20–16; 11:15 am]
BILLING CODE 6715–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–12180 Filed 5–23–16; 8:45 am]
BILLING CODE 6714–01–P
Centers for Disease Control and
Prevention
FEDERAL ELECTION COMMISSION
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
Sunshine Act Meetings
Federal Election Commission.
& TIME: Thursday, May 26, 2016
at 10:00 a.m.
PLACE: 999 E Street NW., Washington,
DC (Ninth Floor).
STATUS: This meeting will be open to
the public.
ITEMS TO BE DISCUSSED:
Proposed Statement of Policy Regarding
the Public Disclosure of Closed
Enforcement Files
Management and Administrative
Matters
Individuals who plan to attend and
require special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact Shawn Woodhead Werth,
Secretary and Clerk, at (202) 694–1040,
at least 72 hours prior to the meeting
date.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
AGENCY:
sradovich on DSK3TPTVN1PROD with NOTICES
DATE
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2016–12248 Filed 5–20–16; 11:15 am]
BILLING CODE 6715–01–P
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) and the
Health Resources and Services
Administration (HRSA) announce the
following committee meeting.
Times and Dates: 8:30 a.m.–5:30 p.m.,
EDT, June 14, 2016; 8:30 a.m.–3:00 p.m.,
EDT, June 15, 2016.
Place: CDC Corporate Square,
Building 8, Conference Room 1–ABC, 8
Corporate Boulevard, Atlanta, Georgia
30329, Telephone: (404) 639–8317. The
meeting is also accessible by
teleconference. Toll-free number +1
(877) 603–4228, Participant code:
42598858.
Status: Open to the public, limited
only by the space available. The meeting
room will accommodate approximately
100 people.
Purpose: This Committee is charged
with advising the Director, CDC and the
Administrator, HRSA, regarding
activities related to prevention and
control of HIV/AIDS, Viral Hepatitis and
other STDs, the support of health care
services to persons living with HIV/
AIDS, and education of health
professionals and the public about HIV/
AIDS, Viral Hepatitis and other STDs.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
32753
Matters For Discussion: Agenda items
include: (1) Syphilis among Men Who
Have Sex with Men (MSM) and
Congenital Syphilis; (2) Update on
CDC’s Medical Monitoring Project; (3)
Discussion on Infectious Diseases
prevention for people who inject drugs
(PWID); (4) Findings of the Institute of
Medicine Committee on A National
Strategy for the Elimination of Hepatitis
B and C: Feasible elimination goals and
possible factors critical for success; and
(5) Updates from Workgroups.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Margie Scott-Cseh, CDC, National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, 1600 Clifton
Road NE., Mailstop E–07, Atlanta,
Georgia 30333; telephone (404) 639–
8317.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–12224 Filed 5–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date
10:30 a.m.–5:00 p.m., EDT, June 14,
2016
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
E:\FR\FM\24MYN1.SGM
24MYN1
sradovich on DSK3TPTVN1PROD with NOTICES
32754
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on March 22, 2016 pursuant
to Executive Order 13708, and will
expire on September 30, 2017.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for
the Subcommittee meeting includes the
following dose reconstruction program
quality management and assurance
activities: dose reconstruction cases
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
under review from Sets 14–18,
including the Oak Ridge sites (Y–12, K–
25, Oak Ridge National Laboratory),
Hanford, Feed Materials Production
Center (‘‘Fernald’’), Mound Plant, Rocky
Flats Plant, Nevada Test Site, Idaho
National Laboratory, and Savannah
River Site; preparation of the Advisory
Board’s next report to the Secretary,
HHS, summarizing the results of
completed dose reconstruction reviews.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll
Free 1 (800) CDC–INFO, Email ocas@
cdc.gov. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–12149 Filed 5–23–16; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
Time and Date
8:00 a.m.–6:00 p.m., EDT, June 22, 2016
8:00 a.m.–5:00 p.m., EDT, June 23, 2016
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road, NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited
only by the space available. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt
June 13, 2016. All requests must contain
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
the name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Please
note that the public comment period
may end before the time indicated,
following the last call for comments.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Written comments
received in advance of the meeting will
be included in the official record of the
meeting.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP Web site: https://
www.cdc.gov/vaccines/acip/.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines. Further, under provisions of
the Affordable Care Act, at section 2713
of the Public Health Service Act,
immunization recommendations of the
ACIP that have been adopted by the
Director of the Centers for Disease
Control and Prevention and appear on
the CDC immunization schedules must
be covered by applicable health plans.
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccines; human
papillomavirus vaccines; influenza;
cholera vaccine; hepatitis vaccines;
safety of maternal Tdap vaccination;
child/adolescent immunization
schedule; Respiratory Syncytial Virus
(RSV) and vaccine supply. A
recommendation vote is scheduled for
meningococcal vaccines and cholera
vaccine. A Vaccines for Children (VFC)
vote is scheduled for meningococcal
vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road, NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Pages 32753-32754]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date
10:30 a.m.-5:00 p.m., EDT, June 14, 2016
Place: Audio Conference Call via FTS Conferencing.
Status: Open to the public, but without a public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written
[[Page 32754]]
comments received in advance of the meeting will be included in the
official record of the meeting. The public is also welcome to listen to
the meeting by joining the teleconference at the USA toll-free, dial-in
number at 1-866-659-0537 and the pass code is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and will expire on September 30,
2017.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for the Subcommittee meeting
includes the following dose reconstruction program quality management
and assurance activities: dose reconstruction cases under review from
Sets 14-18, including the Oak Ridge sites (Y-12, K-25, Oak Ridge
National Laboratory), Hanford, Feed Materials Production Center
(``Fernald''), Mound Plant, Rocky Flats Plant, Nevada Test Site, Idaho
National Laboratory, and Savannah River Site; preparation of the
Advisory Board's next report to the Secretary, HHS, summarizing the
results of completed dose reconstruction reviews.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO,
Email ocas@cdc.gov. The Director, Management Analysis and Services
Office, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-12149 Filed 5-23-16; 8:45 am]
BILLING CODE 4163-19-P
